Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $21-Report Released on 28 January 2024
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Stephen Gengaro has maintained a Hold rating on Core Laboratories (NYSE:CLB) and reduced the price target from $23 to $21. The report was released on January 28, 2024.
January 29, 2024 | 2:25 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stifel analyst Stephen Gengaro maintains a Hold rating on Core Laboratories and lowers the price target from $23 to $21.
The reduction in price target by Stifel suggests a less optimistic outlook for Core Laboratories, which could lead to negative sentiment among investors and potentially a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100